New research findings with Luke O'Neill
10 October 2024 - 8 mins
Podcast Series
The Pat Kenny Show
The drug Ozempic and drugs like it are approved for the treatment of type 2 diabetes and obesity but recent research is suggesting that their benefits may go way beyond that. We hear how with Luke O'Neill Professor of Biochemistry at the school of Immunology, Trinity College.
Series Episodes
